# Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease

> **NCT03263624** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Nail Psoriasis

## Interventions

- **DEVICE:** fractional carbon dioxide laser
- **DRUG:** Tazarotene Cream 0.1%

## Key facts

- **NCT ID:** NCT03263624
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263624, "Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03263624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*